EAM
Erste Asset Management Portfolio holdings
AUM
$11.9B
1-Year Return
22.95%
This Quarter Return
-13.89%
1 Year Return
+22.95%
3 Year Return
+112.82%
5 Year Return
+205.55%
10 Year Return
–
AUM
$4.5B
AUM Growth
-$744M
(-14%)
Cap. Flow
+$122M
Cap. Flow
% of AUM
2.72%
Top 10 Holdings %
Top 10 Hldgs %
18.83%
Holding
979
New
48
Increased
192
Reduced
136
Closed
31
Top Buys
| 1 |
HES
Hess
HES
|
$32.2M |
| 2 |
Netflix
NFLX
|
$31.3M |
| 3 |
Pfizer
PFE
|
$14.6M |
| 4 |
Coca-Cola
KO
|
$12.1M |
| 5 |
East-West Bancorp
EWBC
|
$9.42M |
Top Sells
| 1 |
Bristol-Myers Squibb
BMY
|
$32.2M |
| 2 |
HMHC
Houghton Mifflin Harcourt Company
HMHC
|
$19.3M |
| 3 |
VMW
VMware, Inc
VMW
|
$15.3M |
| 4 |
Coterra Energy
CTRA
|
$12.9M |
| 5 |
Essential Utilities
WTRG
|
$11.4M |
Sector Composition
| 1 | Technology | 29.9% |
| 2 | Healthcare | 19.98% |
| 3 | Consumer Discretionary | 10.77% |
| 4 | Financials | 9.62% |
| 5 | Industrials | 7.74% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
376
Sempra
SRE
$52.9B
| $870K | 0.02% |
11,582
+1,434
| +14% | +$108K |
|
377
Occidental Petroleum
OXY
$45.2B
| $863K | 0.02% |
+14,600
| New | +$863K |
|
378
Albemarle
ALB
$9.6B
| $848K | 0.02% |
4,000
+3,732
| +1,393% | +$791K |
|
379
Sociedad Química y Minera de Chile
SQM
$13.1B
| $843K | 0.02% |
10,000
| – | – |
|
380
Corteva
CTVA
$49.1B
| $840K | 0.02% |
15,400
+6,400
| +71% | +$349K |
|
381
Maravai LifeSciences
MRVI
$363M
| $790K | 0.02% |
28,400
| – | – |
|
382
Omega Healthcare
OHI
$12.7B
| $784K | 0.02% |
26,939
+3,993
| +17% | +$116K |
|
383
Chemours
CC
$2.34B
| $780K | 0.02% |
24,578
+3,142
| +15% | +$99.7K |
|
384
Denali Therapeutics
DNLI
$2.26B
| $780K | 0.02% |
26,900
| – | – |
|
385
Cenovus Energy
CVE
$28.7B
| $775K | 0.02% |
+40,000
| New | +$775K |
|
386
SiriusXM
SIRI
$8.1B
| $775K | 0.02% |
12,679
+1,848
| +17% | +$113K |
|
387
Fate Therapeutics
FATE
$116M
| $764K | 0.02% |
30,700
+10,000
| +48% | +$249K |
|
388
Devon Energy
DVN
$22.1B
| $759K | 0.02% |
13,600
| – | – |
|
389
Vir Biotechnology
VIR
$732M
| $749K | 0.02% |
28,800
| – | – |
|
|
SPLK
390
DELISTED
Splunk Inc
SPLK
| $739K | 0.02% |
8,000
| – | – |
|
391
DexCom
DXCM
$31.6B
| $687K | 0.02% |
9,108
-344
| -4% | -$26K |
|
392
Illinois Tool Works
ITW
$77.6B
| $680K | 0.02% |
3,719
+3,260
| +710% | +$596K |
|
393
Gen Digital
GEN
$18.2B
| $678K | 0.02% |
30,415
+4,672
| +18% | +$104K |
|
394
TSMC
TSM
$1.26T
| $674K | 0.02% |
8,000
-55,700
| -87% | -$4.69M |
|
395
Twist Bioscience
TWST
$1.55B
| $664K | 0.01% |
19,100
+8,000
| +72% | +$278K |
|
396
Harmony Biosciences
HRMY
$2.07B
| $661K | 0.01% |
13,100
| – | – |
|
397
Crown Castle
CCI
$41.9B
| $661K | 0.01% |
+3,952
| New | +$661K |
|
398
Bright Horizons
BFAM
$6.64B
| $655K | 0.01% |
7,733
+600
| +8% | +$50.8K |
|
399
Hamilton Lane
HLNE
$6.41B
| $654K | 0.01% |
9,735
+544
| +6% | +$36.5K |
|
400
International Flavors & Fragrances
IFF
$16.9B
| $651K | 0.01% |
+5,550
| New | +$651K |
|